This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sk Chemicals Co., Ltd.. Active years: 2016-2018.
Location History:
- Yangju-si, KR (2016)
- Gyeonggi-do, KR (2018)
Company Filing History:
Years Active: 2016-2018
Title: Jong-Il Ryu: Innovator in Factor VIII Production
Introduction
Jong-Il Ryu is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biochemistry, particularly in the production and purification of factor VIII and its derivatives. With a total of 2 patents, his work has the potential to impact medical treatments related to blood coagulation.
Latest Patents
Ryu's latest patents focus on a novel process for producing proteins that exhibit factor VIII procoagulant activity. This method involves culturing mammalian cells in a serum-free medium that contains an inhibitor to protect against protease activity released from the cultured cells. The use of dextran sulfate as an inhibitor enhances the homogeneity of the target protein during cultivation. Additionally, his patents describe a purification method for target molecules using affinity chromatography, which separates the desired proteins from the culture medium.
Career Highlights
Jong-Il Ryu is currently associated with Sk Chemicals Co., Ltd., where he continues to advance his research in biochemistry. His innovative approaches to protein production and purification have garnered attention in the scientific community.
Collaborations
Ryu has collaborated with notable colleagues, including In-Young Song and Hun-Taek Kim, contributing to the advancement of their shared research goals.
Conclusion
Jong-Il Ryu's work in the production and purification of factor VIII represents a significant advancement in biochemistry. His innovative methods have the potential to improve medical treatments and enhance the understanding of blood coagulation processes.